OUR PIPELINE

EMPOWERING MEMBERS TO CURE MORE PATIENTS.

The CureWorks collaborative model will be unconstrained by the status quo, which we believe will lead to more cures in less time, with less risk for all involved.

Our goal is to deliver effective and safe immunotherapies to patients earlier in their treatment cycle. Aggregating diverse data from trials will help us increase our overall understanding and accelerate our rate of progress. This approach maximizes the number of potential candidates to present for FDA review and approval and, ultimately, the therapies CureWorks is able to provide to our patients.